ArticleInfection and drug resistance2026
Evaluation of Large Language Models in Infectious Disease Decision-Making: From Examination to Clinical Practice.
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the performance of large language models (LLMs) in infectious disease-specific clinical reasoning and decision-making. Patients and Methods: A comprehensive evaluation of four widely used LLMs-DeepSeek-R1, ChatGPT-5, Grok 3, and Gemini 2.5 Flash-was conducted using a dual assessment framework that combined examination-based questions with real-world clinical cases. LLMs performance was compared with that of infectious disease residents. Examination outcomes were assessed using accuracy and score rates, while clinical case responses were evaluated by expert reviewers using predefined Likert-scale criteria. In addition, doctors' independent clinical decisions were compared with those supported by LLMs to assess the potential value of human-AI collaboration. Results: Across examination-based assessments, LLMs performed comparably to infectious disease residents, with no significant differences observed in accuracy or score rates ( Conclusion: LLMs show substantial potential in infectious disease education and clinical decision support, particularly for knowledge-based tasks. However, their limitations in complex clinical reasoning underscore the necessity of clinician oversight. A human-AI collaborative approach appears to offer the greatest benefit, enhancing decision quality while maintaining clinical safety. Continued refinement of regulatory and medico-legal frameworks is critical to support the safe, ethical, and responsible deployment of LLMs in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.